Recent advances of Pluronic-based copolymers functionalization in biomedical applications
Source abstract
Abstract
The design of polymeric biocompatible nanomaterials for biological and medical applications has received special attention in recent years. Among different polymers, the triblock type copolymers (EO)x(PO)y(EO)x or Pluronics® stand out due its favorable characteristics such as biocompatibility, low tissue adhesion, thermosensitivity, and structural capacity to produce different types of macro and nanostructures, e.g. micelles, vesicles, nanocapsules, nanospheres, and hydrogels. However, Pluronic itself is not the "magic bullet" and its functionalization via chemical synthesis following biologically oriented design rules is usually required aiming to improve its properties. Therefore, this paper presents some of the main publications on new methodologies for synthetic modifications and applications of Pluronic-based nanoconstructs in the biomedical field in the last 15 years. In general, the polymer modifications aim to improve physical-chemical properties related to the micellization process or physical entrapment of drug cargo, responsive stimuli, active targeting, thermosensitivity, gelling ability, and hydrogel formation. Among these applications, it can be highlighted the treatment of malignant neoplasms, infectious diseases, wound healing, cellular regeneration, and tissue engineering. Functionalized Pluronic has also been used for various purposes, including medical diagnosis, medical imaging, and even miniaturization, such as the creation of lab-on-a-chip devices. In this context, this review discusses the main scientific contributions to the designing, optimization, and improvement of covalently functionalized Pluronics aiming at new strategies focused on the multiple areas of the biomedical field.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Hydrogels: synthesis, properties, applications · Advanced Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Nanoparticle-based drug delivery systems for cancer therapy
2. Biomimetic antimicrobial material strategies for combating antibiotic resistant bacteria10.1039/C9BM01393H ↗
3. Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery10.1007/s11356-019-05211-0 ↗
4. Morphologies and functionalities of polymeric nanocarriers as chemical tools for drug delivery: a review10.1016/j.jksus.2017.10.004 ↗
5. Amphiphilic copolymers in biomedical applications: synthesis routes and property control10.1016/j.msec.2021.111952 ↗
6. Fabrication and characterization of Pluronic modified poly(hydroxybutyrate) fibers for potential wound dressing applications10.1016/j.msec.2016.02.074 ↗
7. Chitosan/Pluronic F127 thermosensitive hydrogel as an injectable dexamethasone delivery carrier10.3390/gels8010044 ↗
8. Poloxamer: a versatile tri-block copolymer for biomedical applications10.1016/j.actbio.2020.04.028 ↗
9. Thermosensitive self-assembling block copolymers as drug delivery systems10.3390/polym3020779 ↗
10. Poly(ethylene oxide)-poly(propylene oxide)-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling10.1016/0927-7757(94)03028-X ↗
11. Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances10.1039/C4PY00039K ↗
12. Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association10.1021/ma00087a009 ↗
13. Non-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses10.3390/ma14123197 ↗
14. Non-ionic surfactant effects on innate Pluronic 188 behavior: interactions, and physicochemical and biocompatibility studies10.3390/ijms232213814 ↗
15. Advances in non-covalent crosslinked polymer micelles for biomedical applications10.1016/j.msec.2020.111626 ↗
16. Hydration and conformation of temperature-dependent micellization of PEO-PPO-PEO block copolymers in aqueous solutions by FT-Raman10.1021/la981036w ↗
17. Thermosensitive hydrogel based on PEO–PPO–PEO poloxamers for a controlled in situ release of recombinant adeno-associated viral vectors for effective gene therapy of cartilage defects10.1002/adma.201906508 ↗
18. Poloxamer hydrogels for biomedical applications10.3390/pharmaceutics11120671 ↗
19. Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development10.1016/j.jcis.2019.12.096 ↗
20. Polymeric hydrophilic polymers in targeted drug delivery10.1533/9781845693077.1.42 ↗
21. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview10.1016/j.jconrel.2022.12.017 ↗
22. Intravenous and intratumoral injection of Pluronic P94: the effect of administration route on biodistribution and tumor retention10.1016/j.nano.2017.04.015 ↗
23. Chowdhury · 2017
24. Overview of P-glycoprotein inhibitors: a rational outlook, Brazilian
25. Pluronics and MDR reversal: an update10.1021/mp500298q ↗
26. Paul Ehrlich’s magic bullets10.1056/NEJMp048021 ↗
27. Rapid formation of small unilamellar vesicles (SUV) through low-frequency sonication: an innovative approach10.1016/j.colsurfb.2019.06.027 ↗
28. Preparation and characterization of oligopeptide/M-Pluronic F127 composite membranes10.4028/www.scientific.net/MSF.996.59 ↗
29. Dual-targeting nanocarrier based on glucose and folic acid functionalized pluronic P105 polymeric micelles for enhanced brain distribution
30. Folate receptor-mediated renal-targeting nanoplatform for the specific delivery of triptolide to treat renal ischemia/reperfusion injury10.1021/acsbiomaterials.9b00119 ↗
31. Folic acid modified Pluronic F127 coating Ag2S quantum dot for photoacoustic imaging of tumor cell-targeting10.1088/1361-6528/aa9acc ↗
32. Synthesis of new zinc(II) phthalocyanine conjugates with block copolymers for cancer therapy
33. Preparation of pH sensitive pluronic-docetaxel conjugate micelles to balance the stability and controlled release issues10.3390/ma8020379 ↗
34. Green synthesis of silver nanostructures with amino acid-modified Pluronic F127 for antibacterial applications10.1016/j.apsusc.2019.144449 ↗
35. The thermoviscosifying behavior ofwater-soluble polymer based on graft polymerization of Pluronic F127 with acrylamide and 2-acrylamido-2-methylpropane sulfonic acid sodium salt10.3390/polym11101702 ↗
36. Dual responsive oligo(lysine)-modified Pluronic F127 hydrogels for drug release of 5-fluorouracil10.1039/D0RA03207G ↗
37. Dual regulations of thermosensitive heparin-poloxamer hydrogel using ϵ-polylysine: bioadhesivity and controlled KGF release for enhancing wound healing of endometrial injury10.1021/acsami.7b10211 ↗
38. Injectable poloxamer/graphene oxide hydrogels with well-controlled mechanical and rheological properties10.1002/pat.4654 ↗
39. Current trends and challenges in cancer management and therapy using designer nanomaterials10.1186/s40580-019-0193-2 ↗
40. Corrigendum to “Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity” [Journal of Controlled Release 191 (2014) 34–46] (Journal of Controlled Release (2014) 191 (34–46), (S0168365914003472), (10))10.1016/j.jconrel.2021.07.001 ↗
41. Development of a pluronic-zein-curcumin drug delivery system with effective improvement of hydrophilicity, stability and sustained-release10.1016/j.jcs.2022.103412 ↗
42. Synthesis, characterization, and biological verification of anti-HER2 indocyanine green-doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for targeted photochemotherapy of breast cancer cells10.1186/s12951-017-0274-5 ↗
43. Synthesis, characterization and anti-cancer activity of Pluronic F68–curcumin conjugate micelles10.3109/10717544.2015.1037970 ↗
44. Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: preparation, characterization and application in a vaginal drug delivery system10.1016/j.apsb.2017.03.002 ↗
45. Reaction of glycidyl methacrylate at the hydroxyl and carboxylic groups of poly(vinyl alcohol) and poly(acrylic acid): is this reaction mechanism still unclear?10.1021/jo900033c ↗
46. Thiol/acrylate-modified PEO-PPO-PEO triblocks used as reactive and thermosensitive copolymers10.1021/bm800573e ↗
47. Photo and thermal properties of cinnamoyl Pluronic F-12710.1002/pi.4533 ↗
48. pH-responsive copolymers based on pluronic P123-poly(β-amino ester): synthesis, characterization and application of copolymer micelles10.1016/j.colsurfb.2016.02.033 ↗
49. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(ε-caprolactone) (PCL) amphiphilic block copolymeric nanospheres: II. Thermo- responsive drug release behaviors10.1016/S0168-3659(99)00207-2 ↗
50. Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma10.1016/j.msec.2018.05.011 ↗
51. Influence of poly(ε-caprolactone) end-groups on the temperature-induced macroscopic gelation of Pluronic in aqueous media10.1016/j.eurpolymj.2019.01.033 ↗
52. A review on the recent research of polycaprolactone (PCL)10.4028/www.scientific.net/AMR.1134.249 ↗
53. Effect of PCL end-groups on the self-assembly process of Pluronic in aqueous media10.1039/C7CP07240F ↗
54. Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers10.1016/j.jconrel.2007.05.010 ↗
55. Dissociation and thermal characteristics of poly(acrylic acid) modified pluronic block copolymers in aqueous solution10.1016/j.polymer.2014.05.048 ↗
56. pH-sensitive DOX-loaded PAA-PF127-PAA micelles combined with cryotherapy for treating walker 256 carcinosarcoma in a rat model10.1166/jnn.2018.16409 ↗
57. pH-responsive smart gels of block copolymer [pluronic F127-co-poly(acrylic acid)] for controlled delivery of Ivabradine hydrochloride: its toxicological evaluation10.1007/s10965-019-1872-8 ↗
58. The proton sponge hypothesis: fable or fact?10.1016/j.ejpb.2018.05.034 ↗
59. A polyethylenimine-mimetic biodegradable polycation gene vector and the effect of amine composition in transfection efficiency10.1016/j.biomaterials.2013.02.068 ↗
60. Low-molecular weight polyethylenimine modified with pluronic 123 and RGD- or chimeric RGD-NLS peptide: characteristics and transfection efficacy of their complexes with plasmid DNA10.3390/molecules21050655 ↗
61. Peptide-mediated tumor targeting by a degradable nano gene delivery vector based on Pluronic-modified polyethylenimine10.1186/s11671-016-1337-5 ↗
62. miR-29b and retinoic acid co-delivery: a promising tool to induce a synergistic antitumoral effect in non-small cell lung cancer cells10.1007/s13346-020-00768-7 ↗
63. Poly (propylene imine) dendrimer: a potential nanomaterial for electrochemical application10.1016/j.matchemphys.2020.122641 ↗
64. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery10.1016/j.biomaterials.2014.12.030 ↗
65. Crystallization behavior of poly(ε-caprolactone)/layered double hydroxide nanocomposites10.1002/app.31787 ↗
66. Covalent, non-covalent, encapsulated nanodrug regulate the fate of intra- and extracellular trafficking: impact on cancer and normal cells
67. A cooperative dimensional strategy for enhanced nucleus-targeted delivery of anticancer drugs
68. Self-assembled and pH-responsive polymeric nanomicelles impart effective delivery of paclitaxel to cancer cells10.1039/D1RA01574E ↗
69. Bioreducible cross-linked Pluronic micelles: PH-triggered release of doxorubicin and folate-mediated cellular uptake10.1177/0883911513491642 ↗
70. Pluronic P123-docetaxel conjugate micelles: synthesis characterization, and antitumor activity10.1166/jbn.2013.1706 ↗
71. Spotlight on the delivery of photosensitizers: different approaches for photodynamic-based therapies10.1080/17425247.2017.1307337 ↗
72. Pluronic F-127: an efficient delivery vehicle for 3-(1′-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH or photochlor)10.1111/php.13183 ↗
73. Co-delivery of doxorubicin and pheophorbide A by pluronic F127 micelles for chemo-photodynamic combination therapy of melanoma10.1039/C7TB03179C ↗
74. Modification of thermal and mechanical properties of PEG-PPG-PEG copolymer (F127) with MA-POSS10.3390/polym8090341 ↗
75. pH-sensitive and pluronic-modified pullulan nanogels for greatly improved antitumor in vivo10.1016/j.ijbiomac.2019.07.220 ↗
76. Folate-conjugated chitosan-Pluronic P123 nanogels: synthesis and characterizations towards dual drug delivery10.1155/2019/1067821 ↗
77. Conte · 2014
78. Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells10.1016/j.msec.2016.09.064 ↗
79. Biotin-targeted mixed liposomes: a smart strategy for selective release of a photosensitizer agent in cancer cells10.1016/j.msec.2019.109923 ↗
80. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice10.1016/j.ijpharm.2015.08.083 ↗
81. Biotin-targeted Pluronic® P123/F127 mixed micelles delivering niclosamide: a repositioning strategy to treat drug-resistant lung cancer cells10.1016/j.ijpharm.2016.06.118 ↗
82. Targeted and synergic glioblastoma treatment: multifunctional nanoparticles delivering verteporfin as adjuvant therapy for temozolomide chemotherapy10.1021/acs.molpharmaceut.8b01001 ↗
83. Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery10.1016/j.colsurfb.2015.04.057 ↗
84. A new type of nanogel carrier based on mixed Pluronic loaded with low-dose antitumor drugs10.1007/s11595-019-2144-5 ↗
85. The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis10.1016/j.jconrel.2016.11.016 ↗
86. Folate-targeted Pluronic-chitosan nanocapsules loaded with IR780 for near-infrared fluorescence imaging and photothermal-photodynamic therapy of ovarian cancer10.1016/j.colsurfb.2021.111755 ↗
87. Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity10.1016/j.jconrel.2014.05.044 ↗
88. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles10.1016/j.nano.2014.08.013 ↗
89. Development of chitosan graft pluronic®F127 copolymer nanoparticles containing DNA aptamer for paclitaxel delivery to treat breast cancer cells10.1088/2043-6262/7/2/025018 ↗
90. Peptides as drug delivery vehicles across biological barriers10.1007/s40005-017-0374-0 ↗
91. A redox-sensitive and RAGE-targeting nanocarrier for hepatocellular carcinoma therapy10.1021/acs.molpharmaceut.6b00116 ↗
92. Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies10.2147/IJN.S166584 ↗
93. Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery10.1021/bc700443k ↗
94. Oligoalanine-modified Pluronic-F127 nanocarriers for the delivery of curcumin with enhanced entrapment efficiency10.1080/09205063.2014.924059 ↗
95. Effects of pH-sensitive chain length on release of doxorubicin from mPEG-b-PH-b-PLLA nanoparticles
96. Antibacterial activity of poloxamer-modified montmorillonite clay against E. coli10.1016/j.matlet.2011.06.077 ↗
97. α-Linolenic acid-modified pluronic 127-CS copolymeric micelles for the skin targeted delivery of amphotericin B10.1039/C8NJ03847C ↗
98. Pluronic micelles with suppressing doxorubicin efflux and detoxification for efficiently reversing breast cancer resistance10.1016/j.ejps.2020.105275 ↗
99. Pluronic stabilized Fe3O4 magnetic nanoparticles for intracellular delivery of curcumin10.1039/C6RA21207G ↗
100. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications10.1016/j.biomaterials.2009.06.004 ↗